Clinical Trial Update: Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety, tolerability, and immunogenicity of INO-4800 (DNA vaccine) with electroporation in healthy volunteers for COVID-19. S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Sars-cov-2

Drugs mentioned

• INO-4800 (INO-4800)

Snippet

Sponsor: International Vaccine Institute | Conditions: Coronavirus Infection, SARS-CoV 2 | Phase 1, Phase 2 | Status: COMPLETED